Trial Profile
A phase II clinical trial of DAS181 to treat severely ill hospitalized patients with influenza virus
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 15 Jan 2019
Price :
$35
*
At a glance
- Drugs Oplunofusp (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 15 Jan 2019 New trial record